We are live on
!
Find out more
Aristotle Capital Management Portfolio holdings
AUM
$47.7B
1-Year Est. Return
13.92%
This Fund
S&P 500
This Quarter
Est. Return
+6.36%
1 Year Est. Return
+13.92%
3 Year Est. Return
+50.48%
5 Year Est. Return
+59.96%
10 Year Est. Return
+301.3%
AUM
$47.7B
AUM Growth
-$97.3M
(-0.2%)
Cap. Flow
-$2.67B
Cap. Flow
% of AUM
-5.59%
Top 10 Holdings %
Top 10 Hldgs %
30.22%
Holding
221
New
30
Increased
21
Reduced
134
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Autodesk
ADSK
|
+$813M |
| 2 |
Edwards Lifesciences
EW
|
+$726M |
| 3 |
Devon Energy
DVN
|
+$103M |
| 4 |
MICC
The Magnum Ice Cream Company N.V.
MICC
|
+$60.5M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atmos Energy
ATO
|
+$865M |
| 2 |
Danaher
DHR
|
+$632M |
| 3 |
Cameco
CCJ
|
+$184M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$118M |
| 5 |
Parker-Hannifin
PH
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.37% |
| 2 | Technology | 17.94% |
| 3 | Materials | 10.58% |
| 4 | Miscellaneous | 10.05% |
| 5 | Healthcare | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Morgan Stanley
MS
$337B
| $108M | 0.23% |
518,691
-128,000
| -20% | -$25.3M |
|
|
52
Cameco
CCJ
$43.6B
| $108M | 0.23% |
1,055,857
-1,637,107
| -61% | -$184M |
|
53
Trane Technologies
TT
$98.8B
| $101M | 0.21% |
206,555
-39,000
| -16% | -$18.2M |
|
54
Ingersoll Rand
IR
$30.5B
| $94.2M | 0.2% |
1,148,723
-35,189
| -3% | -$2.72M |
|
|
55
Devon Energy
DVN
$52.1B
| $91.8M | 0.19% |
+2,221,269
| New | +$103M |
|
|
SUNB
56
Sunbelt Rentals Holdings
SUNB
$30B
| $83.1M | 0.17% |
1,110,306
-84,566
| -7% | -$6.34M |
|
57
GSK
GSK
$102B
| $76.7M | 0.16% |
1,463,518
-64,498
| -4% | -$3.41M |
|
|
MICC
58
The Magnum Ice Cream Company N.V.
MICC
$12.3B
| $71M | 0.15% |
4,081,786
+3,889,375
| +2,021% | +$60.5M |
|
59
Haleon
HLN
$44.5B
| $66.2M | 0.14% |
7,090,436
-573,078
| -7% | -$5.33M |
|
60
Accenture
ACN
$116B
| $55.6M | 0.12% |
447,003
-28,093
| -6% | -$4.88M |
|
61
Rentokil
RTO
$11.8B
| $48.4M | 0.1% |
1,692,441
-103,795
| -6% | -$3.29M |
|
|
AKZOY
62
DELISTED
Akzo Nobel NV
AKZOY
| $48.3M | 0.1% |
2,134,139
-97,252
| -4% | -$2.2M |
|
63
Diageo
DEO
$51.7B
| $41.7M | 0.09% |
518,222
+4,803
| +0.9% | +$388K |
|
64
FirstCash
FCFS
$9.51B
| $39.4M | 0.08% |
182,112
-27,602
| -13% | -$5.99M |
|
65
Jazz Pharmaceuticals
JAZZ
$15.9B
| $26.9M | 0.06% |
111,697
-18,848
| -14% | -$4.13M |
|
66
iShares MSCI EAFE ETF
EFA
$79.6B
| $23.8M | 0.05% |
228,865
-238,215
| -51% | -$24.5M |
|
67
iShares 0-3 Month Treasury Bond ETF
SGOV
$104B
| $20.8M | 0.04% |
206,446
-80,937
| -28% | -$8.14M |
|
68
AbbVie
ABBV
$451B
| $16.1M | 0.03% |
63,964
-182
| -0.3% | -$39.2K |
|
69
iShares Russell 1000 Value ETF
IWD
$84.3B
| $13.5M | 0.03% |
55,774
+12,084
| +28% | +$2.81M |
|
70
iShares MSCI South Korea ETF
EWY
$28B
| $11.9M | 0.02% |
58,746
-2,272
| -4% | -$401K |
|
71
Norwegian Cruise Line
NCLH
$7.65B
| $11.3M | 0.02% |
534,649
-73,782
| -12% | -$1.38M |
|
72
Royal Bank of Canada
RY
$283B
| $7.14M | 0.02% |
34,487
| – | – |
|
73
Johnson & Johnson
JNJ
$646B
| $6.53M | 0.01% |
25,712
| – | – |
|
74
Cintas
CTAS
$81.7B
| $6.16M | 0.01% |
36,203
-270
| -0.7% | -$46.7K |
|
|
75
Atmos Energy
ATO
$28.2B
| $5.84M | 0.01% |
33,902
-4,832,579
| -99% | -$865M |
|
Similar funds
SCP
VCMC
EP
Aristotle Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Aristotle Capital Management held 221 positions worth $47.7B, down 0.2% from $47.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Aristotle Capital Management withdrew a net $2.67B in Q2 2026, closing 9 positions and reducing 134 holdings. Its most notable exit was Coterra Energy, an estimated $118M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Materials.
Against the trend, Aristotle Capital Management opened a new position in Edwards Lifesciences worth $784M.
- Aristotle Capital Management's largest Q2 2026 buy was Edwards Lifesciences: 8,665,712 shares worth $784M.
- Aristotle Capital Management added most to Autodesk in Q2 2026, an estimated $813M increase.
- Aristotle Capital Management's biggest Q2 2026 reduction was Atmos Energy, cutting an estimated $865M.
- Aristotle Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $118M.
- Aristotle Capital Management's ten largest holdings make up 30% of its $47.7B portfolio in Q2 2026.
- Aristotle Capital Management opened 30 new positions and closed 9 in Q2 2026.
- Aristotle Capital Management's portfolio value fell 0.2% quarter-over-quarter to $47.7B.
Based on Aristotle Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.